Erie Indemnity (ERIE)
(Delayed Data from NSDQ)
$534.70 USD
+5.23 (0.99%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $534.33 -0.37 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$534.70 USD
+5.23 (0.99%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $534.33 -0.37 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Zacks News
5 Insurance Brokerage Stocks to Benefit From Higher Demand
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, BRO, ERIE and RYAN.
Arthur J. Gallagher (AJG) Rises 17% YTD: More Upside Left?
by Zacks Equity Research
Solid performance of the Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities and effective capital deployment continue to drive Arthur J. Gallagher's (AJG) performance.
Here is Why Growth Investors Should Buy Erie Indemnity (ERIE) Now
by Zacks Equity Research
Erie Indemnity (ERIE) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why 'Trend' Investors Would Love Betting on Erie Indemnity (ERIE)
by Zacks Equity Research
Erie Indemnity (ERIE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Add 5 Low-Beta Stocks to Your Portfolio to Counter Volatility
by Nalak Das
We have narrowed our search to five low-beta stocks. These are: DPZ, ACGL, AZPN, MLM, ERIE.
Zacks.com featured highlights PlayAGS, TETRA, Perdoceo Education, Erie Indemnity and New Oriental Education
by Zacks Equity Research
PlayAGS, TETRA, Perdoceo Education, Erie Indemnity and New Oriental Education have been highlighted in this Screen of The Week article.
5 Stocks With Recent Price Strength to Maximize Your Returns
by Nalak Das
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are AGS, TTI, PRDO, ERIE, EDU.
New Strong Buy Stocks for August 3rd
by Zacks Equity Research
ERIE, RCL, EDU, ACGL and RM have been added to the Zacks Rank #1 (Strong Buy) List on August 3, 2023.
Best Income Stocks to Buy for August 3rd
by Zacks Equity Research
ERIE, RM and HSII made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 3, 2023.
Erie Indemnity (ERIE) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 17.80% and 4.49%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) Rallies 90% YTD: Can It Retain the Bull Run?
by Zacks Equity Research
Solid Medicare and Individual, Family and Small Business performance and financial position continue to drive eHealth (EHTH).
Arthur J. Gallagher (AJG) Shares Up 31% YTD: More Upside Left?
by Zacks Equity Research
Solid performance of the Brokerage and Risk Management segments, strategic buyouts to capitalize on growing market opportunities and effective capital deployment continue to drive Arthur J. Gallagher (AJG).
Should You Retain Willis Towers (WTW) Stock in Your Portfolio?
by Zacks Equity Research
Willis Towers (WTW) is poised to benefit from growing healthcare premiums, increased consulting work and software sales, strategic buyouts and effective capital deployment.
Best Income Stocks to Buy for June 9th
by Zacks Equity Research
CCU, AMR and ERIE made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 9, 2023.
What Makes Erie Indemnity (ERIE) a New Strong Buy Stock
by Zacks Equity Research
Erie Indemnity (ERIE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Brown & Brown (BRO) Gains 10% YTD: Will the Rally Continue?
by Zacks Equity Research
New businesses, better customer retention, premium rate increases across the majority of business lines, strategic acquisitions and strong financial position continue to drive Brown & Brown (BRO)
Zacks Industry Outlook Highlights Marsh & McLennan, Aon, Brown and Brown, Erie Indemnity and Ryan Specialty
by Zacks Equity Research
Marsh & McLennan, Aon, Brown and Brown, Erie Indemnity and Ryan Specialty have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Prospering Insurance Brokerage Industry
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, BRO, ERIE and RYAN.
Arthur J. Gallagher (AJG) Expands Brokerage Business With Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) boosts its brokerage and consulting business with Bernard Benefits and Bernard Healthcare Financial Planning acquisition.
Here's Why Hold is an Apt Strategy for Nasdaq (NDAQ) Stock
by Zacks Equity Research
Improving organic growth, focus on ramping up the on-trading revenue base, buyouts to capitalize on growing market opportunities, effective capital deployment poise Nasdaq (NDAQ) for growth.
Erie Indemnity (ERIE) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
Erie Indemnity (ERIE) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Here's Why You Should Hold Aflac (AFL) in Your Portfolio
by Zacks Equity Research
Lower benefits and expenses, higher net investment income, and improved profit levels from the U.S. business aid Aflac (AFL).
Arthur J. Gallagher (AJG) Boosts Capabilities With IBKB Buyout
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Insurance by Ken Brown acquisition will help consolidate its presence in Florida and Southeast United States.
Brown & Brown (BRO) to Expand UK Presence With Buyout
by Zacks Equity Research
Brown & Brown's (BRO) pending Kentro Capital Limited acquisition will help it boost presence London.
Arthur J. Gallagher (AJG) on a Buyout Spree, Boosts Portfolio
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyouts help it solidify geographical presence as well as consolidate portfolio.